Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fiedler

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|January 16, 2024
Therapy with hypomethlyating agents/venetoclax in patients with newly diagnosed acute myeloid leukaemia requiring admission to the intensive care unit: Possible reduction in side effects with preserved efficacyWalter Fiedler
MMW Fortschritte Der Medizin|February 5, 2026
[Leg swelling in general practice - Differential diagnosis and management]Hans-Walter Fiedler
Expert Opinion on Investigational Drugs|May 15, 2010
Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancerAlexander Schultze, Walter Fiedler
Future Oncology (London, England)|June 21, 2014
Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical developmentMelanie Janning, Walter Fiedler
Anti-Cancer Agents in Medicinal Chemistry|July 27, 2011
Clinical importance and potential use of small molecule inhibitors of focal adhesion kinaseAlexander Schultze, Walter Fiedler
Blood|September 15, 2012
CD146: a new partner for VEGFR2Jasmin Wellbrock, Walter Fiedler
Onkologie|September 25, 2007
Managing side effects of angiogenesis inhibitors in renal cell carcinomaViktor Grünwald, Hans Heinzer, Walter Fiedler
Leukemia Research|January 22, 2008
Prognostic implication of expression of Angiopoietin-2 in acute myeloid leukemiaWalter Fiedler, Gunter Schuch, Sonja Loges
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 23, 2018
Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancerHauke Stamm, Jasmin Wellbrock, Walter Fiedler
Frontiers in Oncology|October 30, 2018
Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer LookLena Behrmann, Jasmin Wellbrock, Walter Fiedler
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|January 16, 2024
Therapy with hypomethlyating agents/venetoclax in patients with newly diagnosed acute myeloid leukaemia requiring admission to the intensive care unit: Possible reduction in side effects with preserved efficacyWalter Fiedler
MMW Fortschritte Der Medizin|February 5, 2026
[Leg swelling in general practice - Differential diagnosis and management]Hans-Walter Fiedler
Expert Opinion on Investigational Drugs|May 15, 2010
Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancerAlexander Schultze, Walter Fiedler
Future Oncology (London, England)|June 21, 2014
Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical developmentMelanie Janning, Walter Fiedler
Anti-Cancer Agents in Medicinal Chemistry|July 27, 2011
Clinical importance and potential use of small molecule inhibitors of focal adhesion kinaseAlexander Schultze, Walter Fiedler
Blood|September 15, 2012
CD146: a new partner for VEGFR2Jasmin Wellbrock, Walter Fiedler
Onkologie|September 25, 2007
Managing side effects of angiogenesis inhibitors in renal cell carcinomaViktor Grünwald, Hans Heinzer, Walter Fiedler
Leukemia Research|January 22, 2008
Prognostic implication of expression of Angiopoietin-2 in acute myeloid leukemiaWalter Fiedler, Gunter Schuch, Sonja Loges
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 23, 2018
Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancerHauke Stamm, Jasmin Wellbrock, Walter Fiedler
Frontiers in Oncology|October 30, 2018
Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer LookLena Behrmann, Jasmin Wellbrock, Walter Fiedler
Pageof 20